Home NPS Pharmaceuticals Receives Orphan Drug Designation for Natpara in Europe
 

Keywords :   


NPS Pharmaceuticals Receives Orphan Drug Designation for Natpara in Europe

2014-01-04 07:51:40| Biotech - Topix.net

NPS Pharmaceuticals, Inc. , a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced that the European Commission has granted orphan drug designation to Natpara for the treatment of hypoparathyroidism.

Tags: europe drug receives designation

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
07.11Lawsuit over FDA's regulatory approval process for carbadox dismissed
07.11Hurricane Rafael Graphics
07.11Hurricane Rafael Forecast Discussion Number 16
07.11Hurricane Rafael Wind Speed Probabilities Number 16
07.11Hurricane Rafael Forecast Advisory Number 16
07.11Hurricane Rafael Public Advisory Number 16
07.11Summary for Hurricane Rafael (AT3/AL182024)
07.11Tropical Depression Fourteen-E Graphics
More »